Gland Pharma - Quaterly Results

19 May 2022 Evaluate
The Revenue for the quarter ended  March 2022 of Rs. 11030.14 millions grew by 24.25 % from Rs. 8877.48 millions.A slim rise of 9.80% was recorded in the Net profit for the quarter ended March 2022 to Rs. 2859.76  millions  From Rs. 2604.51 millions.Operating profit for the quarter ended March 2022 rose to 4136.65 millions as compared to 3749.28 millions of corresponding quarter ended March 2021.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202203 202103 % Var 202203 202103 % Var 202203 202103 % Var
Sales 11030.14 8877.48 24.25 44007.08 34628.76 27.08 44007.08 34628.76 27.08
Other Income 652.34 472.14 38.17 2239.40 1347.76 66.16 2239.40 1347.76 66.16
PBIDT 4136.65 3749.28 10.33 17345.79 14370.43 20.70 17345.79 14370.43 20.70
Interest 20.32 10.21 99.02 52.40 34.11 53.62 52.40 34.11 53.62
PBDT 4116.33 3739.07 10.09 17293.39 14336.32 20.63 17293.39 14336.32 20.63
Depreciation 310.75 249.22 24.69 1102.96 987.80 11.66 1102.96 987.80 11.66
PBT 3805.58 3489.85 9.05 16190.43 13348.52 21.29 16190.43 13348.52 21.29
TAX 945.82 885.34 6.83 4068.88 3378.47 20.44 4068.88 3378.47 20.44
Deferred Tax 93.23 13.13 610.05 140.08 1.20 11573.33 140.08 1.20 11573.33
PAT 2859.76 2604.51 9.80 12121.55 9970.05 21.58 12121.55 9970.05 21.58
Equity 164.30 163.59 0.43 164.30 163.59 0.43 164.30 163.59 0.43
PBIDTM(%) 37.50 42.23 -11.20 39.42 41.50 -5.02 39.42 41.50 -5.02

Gland Pharma Share Price

1643.00 -7.85 (-0.48%)
01-Nov-2024 18:48 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1858.10
Dr. Reddys Lab 1257.70
Cipla 1558.95
Lupin 2204.30
Zydus Lifesciences 1000.25
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.